Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase 3 clinical trial of a novel oral benzimidazole riboside in transplant recipients with cytomegalovirus (CMV) infections that are refractory to available antiviral treatment
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.